Categories
Resources
Your Recalls
Loading...
Get email alerts when new recalls match your interests.
Lack of Assurance of Sterility
cGMP Deviations; released lots were manufactured under similar manufacturing conditions to a previously rejected OOS Lot.
CGMP Deviations: Presence of NDMA impurity detected in product.
Labeling: Incorrect Instructions: Vial label incorrectly instructs healthcare professional to reconstitute product with 16 mL rather than the correct volume of 8 mL of Bacteriostatic Water for Injection with Benzyl Alcohol.
Subpotent: Out of specification for assay at the 12-month time point.
CGMP Deviations: Out of specification test result observed during retrospective review of blend uniformity test data.
Subpotent
Defective Container: loose aluminum cap crimp for the dilution buffer vial present in the NETSPOT Kit (vial 2).
CGMP Deviations: Received notice from supplier of potential -Nitrosodimethylamine (NDMA) amounts above established levels.
Product label does not contain Crustacean Shellfish on the ingredient list or allergen information
CGMP Deviations: Trace amounts of an impurity, N-nitrosodimethylamine (NDMA) was detected in the API Nizatidine.